Conditional Market Authorisation Subject – Economy Context – The drug regulator on Thursday granted Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin Covid-19 vaccines “conditional market authorisation” for the country’s adult population. Concept – Since January last year, the two vaccines have been available under “Emergency Use Authorisation” (EUA), under which 140.89 […]